Our strong balance sheet and consistent cash generation profile provide us with the flexibility to return capital to stockholders while continuing to invest in the growth, innovation, and productivity initiatives that support our long-term strategy.”
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $270 million of Align’s common stock under Align’s $1.0 billion stock repurchase program, which was approved by Align’s Board of Directors in April 2025.
“This $270 million accelerated stock repurchase fulfills the share repurchase commitment we announced in July and is expected to bring our total 2026 share repurchases to approximately $500 million,” said John Morici, Align CFO and Executive Vice President, Global Finance. “This transaction reflects the confidence of our Board and management in Align’s long-term value. Our strong balance sheet and consistent cash generation profile provide us with the flexibility to return capital to stockholders while continuing to invest in the growth, innovation, and productivity initiatives that support our long-term strategy.”
Under the terms of the ASR, Align will make a prepayment of $270 million to Goldman Sachs. The final number of shares to be repurchased will generally be based on the volume-weighted average price of Align common stock during the term of the ASR, less an agreed-upon discount. The ASR transaction is expected to be completed on or about December 29, 2026, although completion may occur earlier in certain circumstances. The ASR will be funded with Align’s cash on hand.
Following the $270 million ASR, Align expects approximately $330 million to remain available for future repurchases under the $1.0 billion stock repurchase program. As of September 30, 2026, Align had approximately $1.145 billion in cash and cash equivalents.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world; iTero™ intraoral scanners and services; and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 307,000 doctor customers and are key to accessing Align’s 600 million-consumer market opportunity worldwide.
Over the past 29 years, Align has helped doctors treat approximately 24.2 million patients with the Invisalign System and is driving the evolution of digital dentistry through the Align™ Digital Platform, its integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and general practitioner (GP) dentists, and lab partners.
Invisalign, iTero, exocad, Align, Align Digital Platform, and iTero Lumina are trademarks of Align Technology, Inc.
Source: https://www.aligntech.com/
News 18 November 2026
Angelalign Technology Appoints Marco Gadola as Senior Advisor
(6699.HK) (“Angel”), a global clear aligner leader, recently announced that Marco Gadola has joined the company as Senior Advisor.
News 16 November 2026
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exo
News 03 November 2026
Five-Year Pledge to the AAO Foundation Advances Research, Education, Mentorship, and Leadership to Help Shape the Future of Orthodontics
News 30 October 2026
Alliance pairs RipeGlobal’s Clinical Performance Platform with Clear Aligner Advisor’s brand-agnostic clear aligner adoption model.
News 16 October 2026
Align Technology to Report Q3 2026 Financial Results October 28
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
Products 18 November 2026
News 18 November 2026
Angelalign Technology Appoints Marco Gadola as Senior Advisor
(6699.HK) (“Angel”), a global clear aligner leader, recently announced that Marco Gadola has joined the company as Senior Advisor.
Editorials 18 November 2026
The Pediatric Dentistry Alumni Association supports the IU Pediatric Dentistry Department and students in a variety of ways.
Orthodontics 18 November 2026
This peer-reviewed orthodontics article summarizes clinical evidence from Dental press journal of orthodontics (2024). It focuses on findings that may help dental professionals evaluate treatment...
Products 17 November 2026
Dentsply Sirona Manufactures 100,000th Heliodent Plus X-Ray Unit
The 100,000-unit milestone reflects decades of clinician trust and the growing importance of connected imaging workflows in modern dentistry.